Pharmac’s anti-HIV drug subsidy is an own goal for LGBTPharmac is to fund the HIV drug Truvada for an estimated 4000 at-risk New Zealanders. But with the plan set to cost the taxpayer millions in subsidies, there’s got to be a better way, argues Act's Stephen Berry. By Stephen Berry | 23rd March, 2018Guest writer
